Dbv technologies to participate in upcoming investor conference

Montrouge, france, may 9, 2023 d bv technologies to participate in upcoming investor conference dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced its participation in the jmp securities life sciences conference taking place may 15-16 in new york, ny. daniel tassÉ, chief executive officer, will make a company presentation on monday, may 15, 2023 at 9:00am et, as well as participate in one-on-one investor meetings throughout the day.
DBVT Ratings Summary
Quant
DBVT Quant Ranking
Sector
Industry
Quant Rating
Quant Score